JP2015536326A5 - - Google Patents

Download PDF

Info

Publication number
JP2015536326A5
JP2015536326A5 JP2015538056A JP2015538056A JP2015536326A5 JP 2015536326 A5 JP2015536326 A5 JP 2015536326A5 JP 2015538056 A JP2015538056 A JP 2015538056A JP 2015538056 A JP2015538056 A JP 2015538056A JP 2015536326 A5 JP2015536326 A5 JP 2015536326A5
Authority
JP
Japan
Prior art keywords
amdac
individual
effective amount
therapeutically effective
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015538056A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536326A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/065653 external-priority patent/WO2014063035A2/en
Publication of JP2015536326A publication Critical patent/JP2015536326A/ja
Publication of JP2015536326A5 publication Critical patent/JP2015536326A5/ja
Pending legal-status Critical Current

Links

JP2015538056A 2012-10-19 2013-10-18 羊膜由来接着細胞を利用する疼痛の治療 Pending JP2015536326A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261716091P 2012-10-19 2012-10-19
US61/716,091 2012-10-19
US201361783752P 2013-03-14 2013-03-14
US61/783,752 2013-03-14
PCT/US2013/065653 WO2014063035A2 (en) 2012-10-19 2013-10-18 Treatment of pain using amnion derived adherent cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018132024A Division JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療

Publications (2)

Publication Number Publication Date
JP2015536326A JP2015536326A (ja) 2015-12-21
JP2015536326A5 true JP2015536326A5 (OSRAM) 2016-12-08

Family

ID=50488901

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015538056A Pending JP2015536326A (ja) 2012-10-19 2013-10-18 羊膜由来接着細胞を利用する疼痛の治療
JP2018132024A Pending JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療
JP2020104367A Withdrawn JP2020180128A (ja) 2012-10-19 2020-06-17 羊膜由来接着細胞を利用する疼痛の治療
JP2022091267A Active JP7315755B2 (ja) 2012-10-19 2022-06-06 羊膜由来接着細胞を利用する疼痛の治療

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018132024A Pending JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療
JP2020104367A Withdrawn JP2020180128A (ja) 2012-10-19 2020-06-17 羊膜由来接着細胞を利用する疼痛の治療
JP2022091267A Active JP7315755B2 (ja) 2012-10-19 2022-06-06 羊膜由来接着細胞を利用する疼痛の治療

Country Status (6)

Country Link
US (1) US20160166618A1 (OSRAM)
EP (1) EP2909314B1 (OSRAM)
JP (4) JP2015536326A (OSRAM)
CA (1) CA2888772A1 (OSRAM)
DK (1) DK2909314T3 (OSRAM)
WO (1) WO2014063035A2 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113679740A (zh) 2013-11-15 2021-11-23 人类起源公司 包含人胎盘灌注液细胞、其亚群的组合物及其用途
CN113679741B (zh) * 2021-09-13 2023-09-19 北京大学第一医院 人羊膜上皮干细胞在制备治疗顺铂诱导的急性肾损伤的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542349A (ja) 1999-04-16 2002-12-10 ダブリューエム・マーシュ・ライス・ユニバーシティー ポリ(プロピレンフマラート)−ジアクリレートマクロマーで交差結合された生体分解性のポリ(プロピレンフマラート)ネットワーク
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
WO2002004448A2 (en) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
EP2336299A1 (en) 2001-02-14 2011-06-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
ES2708933T3 (es) 2005-12-29 2019-04-12 Celularity Inc Poblaciones de células madre placentarias
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
CN102282252B (zh) * 2008-11-19 2017-07-04 人类起源公司 羊膜来源的贴壁细胞
ES2553712T3 (es) * 2009-11-30 2015-12-11 Pluristem Ltd. Células adherentes de la placenta y uso de las mismas en el tratamiento de enfermedad
BR112013011643A2 (pt) * 2010-11-16 2016-08-09 Giuseppe Marineo aparelho e método para supressão rápida de dor neuropática, oncológica e pediátrica, resistente a opiatos e a eletroanalgesia convencional
KR20190114045A (ko) * 2010-12-17 2019-10-08 안트로제네시스 코포레이션 양막 유래 부착성 세포를 사용한, 면역-관련 질환 및 장애의 치료
WO2012092480A1 (en) * 2010-12-30 2012-07-05 Anthirogenesis Corporation Compositions comprising amnion derived adherent cells and platelet-rich plasma

Similar Documents

Publication Publication Date Title
IL239923A0 (en) Solid solution compositions and use in cardiovascular disease
SI3594348T1 (sl) Sestavki kratko aktivirajoče rna c/ebp alfa in postopki uporabe
PH12014502481A1 (en) Use of pro-fungicides of uk-2a for control of black sigatoka
DK2996701T3 (da) Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose
IL272308A (en) Use of inhaled nitric oxide for the improvement of right and/or left ventricular function
JP2012500090A5 (OSRAM)
CL2013000238A1 (es) Uso de inhibores de la succinato deshidrogenasa y/o inhibidores del complejo iii para mejorar la relacion entre microorganismos dañinos y beneficiosos.
JP2014530840A5 (OSRAM)
IL234508B (en) Inhalation of nitric oxide for treating respiratory diseases
HUE040044T2 (hu) Fumarátok prodrugjai, és azok alkalmazása különbözõ betegségek kezelésében
PL2612551T3 (pl) Kompozycja roztoczy zawierająca roztocza drapieżnego i unieruchomiony żer w kontakcie ze środkiem ograniczającym grzyby oraz sposoby i zastosowania dotyczące stosowania wspomnianej kompozycji
PT2848097T (pt) Dispositivo para o tratamento de plasma de superfícies humanas, animais ou de plantas, em particular da pele ou de áreas de membrana mucosa
JP2012140442A5 (OSRAM)
IL234101B (en) Compositions comprising acamprosate and baclofen for use in the treatment of parkinsonism
PL3087178T3 (pl) Sposób wytwarzania oksydaz szczawianowych o aktywności optymalnej bliskiej ph fizjologicznemu i zastosowanie takich rekombinowanych oksydaz szczawianowych w leczeniu chorób związanych ze szczawianem
WO2015066197A3 (en) Cardiac neural crest cells and methods of use thereof
DK3016665T3 (da) Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser
EP2951286A4 (en) RECOMBINANT MICROORGANISMS WITH NADPH-DEPENDENT ENZYMES AND METHOD FOR THE PRODUCTION THEREOF
JP2014530176A5 (OSRAM)
HK1219690A1 (zh) 利用抗生素来治疗超重和肥胖患者感染的方法
HK1206984A1 (en) Combination therapy of anti-mif antibodies and glucocorticoids
JP2015044878A5 (OSRAM)
JP2014526564A5 (OSRAM)
JP2013100370A5 (OSRAM)
HK1194912A2 (en) Growth factor concentrate and the use thereof